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Abstracts / Urological Science 27 (2016) S24eS35S26acinar proliferation as well as prostatic intraepithelial neoplasia. 14 (36.8%)
patients in ASAP group were later diagnosed as prostate cancer, 6 (23.1%)
patients in PIN group were later diagnosed as prostate cancer, and 100%
patients in ASAP+PIN group were later diagnosed as prostate cancer.
Conclusion: Patients with a diagnosis of ASAP or extensive high grade PIN
during prostate biopsy had a higher chance of developing prostate cancer,
especially for patients with a simultaneous diagnosis of ASAP + PIN in the
same biopsy. These patients should receive second time biopsy during
follow up. Most cancer of the cancer in these patients could be detected
within twice re-biopsy.
IPD08:
NEW CIRCULATING TUMOR CELLS (CTCS) EVALUATION METHOD IN
PROSTATE CANCER
TakehikoNakasato 1,MichioNaoe 1, KazukoTujiyama1, YukiMatui 1, Kazuhiko
Oshinomi1, Jun Morita 1, Kohzo Fuji 1, Yoshio Ogawa M.D1, Masayuki
Ishige 2, Kousuke Osawa 2, Masaharu Matuzaki 2. 1Department of Urology,
Showa University School of Medicine, Tokyo, Japan; 2On-chip Biotechnologies
Co., Ltd., Japan
Purpose: AR-V7 is one of a splicing variant of the Androgen receptor (AR).
It cause castration resistant prostate cancer (CRPC).
Incontrast, CTCs is expected as a predictive factor for patient's prognosis
and as a biomarker of the disease.
CellSearch is the only FDA approval method as an evaluation of CTCs
ensuring the quantitative evaluation. This methodology is depending on
the expression of EpCAM and CK. However, the decrease expression of
EpCAM and CK caused by Epithelial-Mesenchymal Transition (EMT) can be
an obstacle to CTC detection.
In recent years, AdnaTest is used for the evaluation of CRPC. It captures CTC
depending on EpCAM and Her2 expression on cancer cells, then assess the
presence of AR-V7 mRNA. But, this method is semi-quantitative and also
depending on expression of EpCAM.
We consider it is important to know the number of ARV-7 positive cells
accurately. Because, CTCs of each prostate cancer patients are
heterogeneous.
The aim of our study is to establish a new method of improved detection
rate of EpCAM and CK-negative cells (i.e EMTcells), ensure the quantitative
evaluation and assess the number of AR-V7-positive cells.
Materials and Methods: LNcap was used as hormone sensitive prostate
cancer (HSPC) model, and Vcap, PC3 and Du145 were used as CRPC model.
Peripheral blood mononuclear cell (PBMC) and VMRC-RCW (Renal cell
carcinoma cell) were used as negative control.
CK and EpCAM antibodies were used as CTC-speciﬁc antibodies.PSA, PSMA
and AR-FL antibody were used as prostate-speciﬁc antibodies, cells which
show positivitiys for those antiodies within peripheral blood were
considered as CTCs.In addition, vimentin antibody was used for the pur-
pose of evaluating the EMT cells.
AR-V7 antibody was used as a biomarker for prostate cancer. On-chip sort
was used for quantitative assessment of CTCs.
Conclusion: Negativity of CK-Ab for LNCap and EpCAM-Ab for PC3 may
indicate that EMToccurs in LNCap and PC3. Positivity of PSMA-Ab, PSA-Ab
and AR-FL-Ab for LNCap indicates the possibility of improving the
detection rate of CTC. Positivity of AR-V7-Ab for Vcap and low positivity
for LNcap were likely to be the evaluation of new biomarkers in CTC
studies.
IPD09:
THE IMPACT OF TUMOR LOCATIONS ON LOCAL RECURRENCES IN
PROSTATE CANCER PATIENTS RECEIVING CRYOABLATION
Shih-Chun Hung, Chung-Hsin Chen, Yeong-Shiau Pu. Department of
Urology, National Taiwan University Hospital, National Taiwan University
College of Medicine, Taipei, Taiwan
Purpose: To evaluate the impact of tumor locations on local recurrences in
prostate cancer patient who received cryoablation
Materials and Methods: A total 255 patients with prostate cancer who
received primary cryoablation in National Taiwan University Hospital be-
tween January 2008 and December 2012 were enrolled. During follow-up,biochemical failure (Phoenix criteria) would trigger prostate biopsies.
Local recurrence refers to pathologically proven prostate cancer in prostate
and seminal vesicles. The prostate was deﬁned into eight areas: left lateral
(LL), left medial (LM), left apex (LA), right lateral (RL), right medial (RM),
right apex (RA), anterior and midline posterior (PM). The seminal vesicles
also deﬁned as one area each: left seminal vesicle (LSV), right seminal
vesicle (RSV). We analyzed the prostate cancer recurrence rate of each area
after primary cryoablation.
Results: A total of 46 (18.0%) patients had local recurrences during a me-
dian follow-up duration of 5 years. In the primary tumor areas, local
recurrence rates were 7.1% (RM), 3.4% (RA), 2.4% (RSV), 2.6% (LSV), 1.1%
(LM), 2.1% (LL), and 0 (RL, anterior, PM, LA). For the areas with negative
results for malignancy in pre-operative prostate biopsies, local recurrence
rates were 2.4% (RSV), 1.1% (RL) and 0 (other areas). For patients whose
anterior and PM areas were not routinely examed in pre-operative prostate
biopsy, local recurrence rates were 3.3% (anterior) and 1.7% (PM). Multi-
variate analysis revealed higher tumor stages, and tumor locations at RM,
and anterior areas were associated with higher risk of local recurrence.
Those patients with previously proved cancer distribution at the right
medial had highest recurrence rate at this area.
Conclusion: Limited to the nature of cryoablation and preservation of vital
organs nearby, tumor locations in prostate would interfere with the suc-
cessful rate of prostate cryoablation. To improve oncological outcomes,
detailed and accurate tumor locations is essential for prostate patients
who plan to receive cryoablation.
IPD10:
THE ONCOLOGICAL OUTCOMES AND SURVEILLANCE POLICY OF
TESTICULAR CANCER: 6-YEAR SINGLE CENTER EXPERIENCE IN TAIWAN
Yung-Ting Cheng, Kuo-How Huang, Yeong-Shiau Pu. Department of
Urology, National Taiwan University Hospital, Taiwan
Purpose: We investigated the treatment outcome of testicular cancer in
Taiwan, given globally rise in incidence in recent decades.
Materials and Methods: From February 2010 to October 2015, we retro-
spectively collected patients with the conﬁrmed diagnosis of testicular
cancer. Clinical data, pathological details and treatment outcomes were
analyzed by reviewing medical records.
Results: A total of 81 patients with testicular cancer were enrolled; 40
(49.4%) had seminoma and 41(50.6%) had non-seminoma germ cell cancer.
The median age was 51 years old in seminoma and 30 years old in non-
seminoma group. The median follow up period was 30 months (range 1 to
70).
The staging in seminoma group showed 36 (90%) stage I, 1 (2.5%) stage IS, 2
(5%) stage II and 1 (2.5%) stage III. The staging in non-seminoma group was
29 (70%) stage I, 4 (10%) stage IS, 3 (7%) stage II and 5 (12%) stage III.
Approximately 97% of patients (35/36) with stage I seminoma and 90% (26/
29) of patients with stage I non-seminoma accepted active surveillance.
The overall recurrence rates were 12.5 % in seminoma and 31.7% in non-
seminoma group. Only two patients in Non-seminoma group died of
cancer. The 5-year recurrence free survival was 94.2% in seminoma and
84.2% in non-seminoma group. Five year overall survival yielded favorable
results: 100% in seminoma and 94.2% in non-seminoma group.
Conclusion: Our study provided the latest evidence on oncological out-
comes of testicular cancer. Active Surveillance in stage I testicular cancer
yielded good prognosis and served as a treatment option.
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IPD11:
KETAMINE ABUSE AND LOWER URINARY TRACT SYMPTOMS: A SURVEY
FROM DRUG REHABILITATION CENTERS IN TAIWAN
Ching-Heng Yen, Sheng-Tang Wu, Tai-Lung Cha, En Meng. Divisions of
Urology, Department of Surgery, Tri-Service General Hospital, National
Defense Medical Center, Taipei, Taiwan
Purpose: Ketamine is the most commonly abused psychotropic substance
among youngsters in Taiwan. Long-term ketamine use can cause chronic
Abstracts / Urological Science 27 (2016) S24eS35 S27cystitis and severe lower urinary tract symptoms (LUTS). We conducted an
in-depth epidemiological study to better understand the correlation be-
tween ketamine abuse and LUTS.
Materials and Methods: The survey was conducted in two private reha-
bilitation centers in Taiwan. Through self-administered questionnaires
(OABSS, IPSS, ICSI, ICPI and VAS), records of inmates, such as gender, age,
and details of using ketamine, including the way, amount, duration of
using ketamine as well as symptoms of urinary tract were obtained. Data
processing and statistical analysis were performed using statistical soft-
ware SPSS v.17. We analyzed all kinds of relative factors causing ketamine
cystitis and off factor, and established an occurrence and severity fore-
casting module.
Results: 106 ketamine abusers completed the questionnaires, including 11
women and 95 men. LUTS occurred after using ketamine for 24.67±26.36
(mean± SD) months. Most of them combined snoring and smoking of the
ketamine. Leading symptoms included frequency (67.3%), incomplete
voiding (66.3%) and nocturia (61.2%). The scores of OABSS, IPSS, ICSI, ICPI
and VAS were 5.23±4.37, 13.11±10.62, 11.47±6.78, 9.92±5.65, 2.89±3.48,
respectively. 79.2% of ketamine abusers admitted a history of poly-
substance abuse, although none of them had taken drugs other than ke-
tamine regularly. Smoking of ketamine was negatively correlated with
symptom scores in IPSS-S, ICSI and ICPI (P<0.05). OABSS signiﬁcantly
increased while combine using ketamine and Marijuana (P¼0.016). Com-
bination with 3,4-methylenedioxy-methamphetamine (MDMA) usage
signiﬁcantly increased the ICPI score (P¼0.034).
Conclusion: Ketamine abuse can induce severe storage symptoms
depending on the duration of using ketamine. Snorting of ketamine may
cause worsen LUTS than smoking. Combine using ketamine and certain
substances may exacerbate LUTS. With this model as a platform, further
prospective studies are warranted to investigate the appropriate choice of
treatment for this new clinical entity.
IPD12:
EVALUATION OF TREATMENT OUTCOMES IN PELVIC FLOOR MUSCLE
TRAINING WITH BIOFEEDBACK VERSUS INTRA-VAGINAL ELECTRICAL
STIMULATION IN WOMEN WITH URINARY INCONTINENCE IN HONG
KONG PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL
K.W. Yeung, K.L. Lui, W.F. Ho, C.M. Li, C.W. Fan, C.N. Tang.
Purpose: In Hong Kong, the prevalence of Female urinary incontinence is
around 35% and around 18% (~60,000 female) suffered from serve incon-
tinence. However, due to the fact that many women have poor coordina-
tion of pelvic ﬂoor muscle it leads to unsatisfactory treatment outcomes.
Few studies have compared the effectiveness of biofeedback pelvic ﬂoor
muscle training against intra-vaginal electrical stimulation in treating
urinary incontinence.
To evaluate the treatment outcomes and effectiveness of biofeedback
pelvic ﬂoor muscle training against intra-vaginal electrical stimulation for
female patients with urinary incontinence.
Materials and Methods: All patients who attended the female urinary
incontinence clinic from January 2014 to December 2015 were recruited
into the study and the outcomes were analyzed. All patients follow a
standard treatment protocol for the ﬁrst three months, they were taught
how to perform pelvic ﬂoor muscle training, life style modiﬁcation edu-
cation, etiology of urinary incontinence education and initial assessment
of symptom scores (UDI-6, IIQ7), no. of pad used and the time interval
between each micturition were documented. For those patients with poor
outcomes, patient would choose either using biofeedback pelvic ﬂoor
training or intra-vaginal stimulation for further three months. Symptom
scores were reassessed after therapy.
Results: During the study period, 1896 patients were recruited into the
study. Their ages were between 41e83 (mean 58.8). The average duration
of urinary incontinence (UI) was 4.5 years. Forty percent has mixed urinary
incontinence, 48% had stress incontinence and 12% had urge incontinence.
107 patients (5.6%) failed to show any signiﬁcant improvement despite
three months of initial treatment, of which 62 patients (57.9%) were then
proceeded to the intra-vaginal electrical stimulation group and 45 patients
(42.1%) to the biofeedback pelvic ﬂoor muscle-training group. After afurther 12 weeks of treatments, the intra-vaginal stimulation group, had
decreased UDI-6 of 1.4 (P<0.05) and IIQ7 decreased of 1.2 (P<0.05). The
biofeedback pelvic ﬂoor muscle training group had decreased UDI-6 of 2.2
(P<0.05) and IIQ7 of 2.3 (P<0.05). The no. of pad used per day reduced from
2.4 to 1.2(P<0.05) in intra-vaginal stimulation group; 2.3 to 2.1 (P< 0.05)
for the biofeedback pelvic ﬂoor muscle training group. The time interval
between each micturition increased from 1.4 hour to 2.8 hours (P< 0.05)
for both groups.
Conclusion: The results of this study showed that the intra-vaginal
stimulation and biofeedback were both equally effective for poor
responding patients. For the biofeedback group, the symptom scores and
quality of life scores showed better improvement comparing to the intra-
vaginal group. This may be because biofeedback is comparatively more
comfortable than intra-vaginal stimulation, not all patients accept intra-
vaginal probe insertion and for some patients with atrophic vagina,
introduction of probe may be painful. For the actual no. of pad used, the
intra-vaginal stimulation group showed a much more signiﬁcant
improvement. This may be accounted by the fact that direct stimulation
of pelvic ﬂoor muscle is useful for patients with poor active movement.
The drawback of this study is that the treatment options were patient
driven and not randomized but the advantage of patient driven treat-
ment is that patients are very compliance to time consuming rehabili-
tation program.
IPD13:
A CLINICAL NOMOGRAM FOR PREDICTING BLADDER OUTLET
OBSTRUCTION IN NON-NEUROGENIC MALE PATIENTS WITH
OVERACTIVE BLADDER
Wei-Jen Chen 1, Yu-Hua Fan 1,2,3, Alex T.L. Lin 1,2,3, Kuang-Kuo
Chen 1,2,3. 1Department of Urology, Taipei Veterans General Hospital, Taipei,
Taiwan; 2Department of Urology, School of Medicine, Taipei, Taiwan; 3 Shu-
Tien Urological Science Research Center, National Yang-Ming University,
Taipei, Taiwan
Purpose: Bladder outlet obstruction (BOO) is a common cause of over-
active bladder (OAB) symptoms in men, but not all men with OAB symp-
toms have BOO. The strategies for treatment of OAB symptoms are
different in men with BOO and those without BOO. Pressure-ﬂow studies
are considered the reference standard to diagnose BOO. However, the
procedure is invasive, expensive and time-consuming. A non-invasive
diagnostic method for BOO in men with OAB symptoms is warranted. The
nomogram creates a simple graphical representation of a statistically
predictive model which generates a numerical probability of a clinical
event. In this study, we want to develop a nomogram for detection of BOO
in male patients with OAB symptoms.
Materials and Methods: We prospectively recruited male patients pre-
senting with OAB symptoms from our urology outpatient clinic between
August 2008 and July 2015. Patients with overt neurological disorders
were excluded. All patients received the prostate speciﬁc antigen (PSA) test
and transabdominal ultrasound which provided the information of intra-
vesical prostatic protrusion (IPP), prostate volume (PV) and detrusor wall
thickness (DWT). Symptom severity was evaluated with International
Prostate Symptoms Score (IPSS), Overactive Bladder Symptom Score
(OABSS). All patients underwent catheter-free uroﬂowmetry, post-void
residual urine measurement and urodynamic pressure-ﬂow studies. BOO
was deﬁned based on a provisional ICS method for the deﬁnition of
obstruction, which deﬁned BOO as (PdetQmax-2Qmax) > 40. Multivariable
regression analysis was performed to assist in choosing candidate pre-
dictors to build up a nomogram. Internal validation of the nomogram was
performed.
Results: A total of 211 patients were enrolled. The mean age of the patients
was 73.6 years (range 52e91). BOO was diagnosed in 118 patients. Among
univariate analysis, patients with BOO had a higher prevalence of PSA>2
(p¼0.001), PV>30 (p¼0.003), longer IPP (p<0.001), and larger Qmax
(p<0.001), Qmean (p<0.001) on uroﬂowmetry. Among multivariate anal-
ysis, only IPP (p¼0.014) is statistically important, with odds ratio 3.119
(95% CI: 1.259e7.722). A nomogram, demonstrating a predictive accuracy
of 70%, was constructed from PSA, IPP and catheter-free Qmax.
